The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.18
Bid: 15.06
Ask: 15.14
Change: 0.24 (1.61%)
Spread: 0.08 (0.531%)
Open: 15.50
High: 15.50
Low: 14.66
Prev. Close: 14.94
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OPERATIONAL UPDATE

4 Feb 2013 07:00

RNS Number : 0123X
EnQuest PLC
04 February 2013
 



EnQuest PLC, 04 February 2013.

OPERATIONAL UPDATE

 

In relation to EnQuest's current 2022 5.5% bond issue EnQuest will shortly publish a supplementary prospectus, incorporating certain corrections. In addition, EnQuest today provides the following operational update, which is anticipated to be reflected in the supplementary prospectus in due course.

 

Production Summary

 

EnQuest had another good operational performance during 2012, with average daily production of 22,802 Boepd, which compares with the guidance range of average production of 20,000 to 24,000 Boepd and reflected good year end production performances from all of EnQuest's fields.

 

Alma/Galia and Thistle Field Approvals

 

EnQuest's Board has approved an increase in the scope and specification of the Alma/Galia project with the objective of extending the field life, optimising operating costs and enabling a potential second phase development. These changes, which are subject to the normal partner approval process, are expected to extend the FPSO vessel life materially (up to 15 years), and to add additional wells in any second development phase. With the extended field life, the gross field 2P reserves are increased from 29 MMBoe to 34 MMBoe as audited by Gaffney Cline for the existing first phase of development which excludes possible incremental 2C resources for a second phase. Results of all wells drilled to date have been at or better than prognosis. EnQuest will review effects of the well results on reserves, after all wells are completed and analysed.

 

These improvements in adding swivel capacity and extending vessel and project life are expected to increase the gross capital expenditure for the project by approximately $200m. This includes $100m of costs relating to compliance with recent UKCS marine code changes which require upgrades to the mooring system and strengthening of the swivel and vessel hull. In addition, ongoing operations have been impacted by weather related and other cost factors which have resulted in an increase of approximately $100m to the previous capital expenditure estimates. The gross capital expenditure for the Alma/Galia project, in which EnQuest has a 65% working interest, is now expected to total $1.2bn, plus $0.1bn in contingency and growth allowances.

 

In spite of the capital cost increases, the benefits of the extended life related reserves increase and operational improvements to the project will have a positive net present value impact on EnQuest in the first phase of the development. The improvements also create increased potential for additional reserves and value in a potential second phase.

 

EnQuest's Board has also approved the sanctioning of the next phase of the Thistle late life extension project, facilitated as it has been by its qualification for the Brown Field Allowances programme announced by the Government late in 2012.

 

Amjad Bseisu, Chief Executive, said

"It is good to be able to report average production of 22,802 Boepd for 2012, above the middle of the range of our guidance, which is a testament to the success of our drilling programme and good reservoir management.

 

First oil for the Alma/Galia project is still anticipated for Q4 2013. The first phase of the project is now expected to generate significantly greater returns than those foreseen at the time of sanction. The further increase to 34 MMboe in gross 2P reserves for Alma/Galia represents a more attractive first phase development and, with the newly sanctioned improvements, more potential reserves with a second phase."

 

 

ENDS

 

For further information please contact:

 

EnQuest PLC Tel: +44 (0)20 7925 4900

Michael Waring (Head of Communications & Investor Relations)

 

RLM Finsbury Tel: +44 (0)20 7251 3801

James Murgatroyd

Conor McClafferty

Dorothy Burwell

 

Notes to editors

EnQuest is the largest UK independent producer of oil in the UK North Sea. EnQuest trades on both the London Stock Exchange and the NASDAQ OMX Stockholm. It is a constituent of the FTSE 250 index. Its assets include the Thistle, Deveron, Heather, Broom, West Don, Don Southwest and Conrie producing fields and the Alma and Galia development. At the end of June 2012, EnQuest had working interests in 29 production licences covering 36 blocks or part blocks in the UKCS, of which 22 licences are operated by EnQuest.

 

Forward looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectation and plans, strategy, management's objectives, future performance, reserves, production, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this presentation should be construed as a profit forecast. Past share performance cannot be relied on as a guide to future performance.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKALEDPDEEF
Date   Source Headline
23rd Feb 20224:16 pmRNSHolding(s) in Company
17th Feb 20221:51 pmRNSHolding(s) in Company
16th Feb 20224:57 pmRNSHolding(s) in Company
15th Feb 20223:00 pmRNSHolding(s) in Company
11th Feb 202210:00 amRNSDirector/PDMR Shareholding
3rd Feb 20227:00 amRNSOperations update
7th Jan 20229:32 amRNSDirector/PDMR Shareholding
22nd Dec 20218:36 amRNSDirectorate Change
20th Dec 20213:56 pmRNSDirector/PDMR Shareholding
1st Dec 202110:44 amRNSHolding(s) in Company
26th Nov 202110:44 amRNSHolding(s) in Company
24th Nov 20211:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:23 pmRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSOperations update
8th Nov 20213:59 pmRNSHolding(s) in Company
29th Oct 20211:37 pmRNSHolding(s) in Company
25th Oct 20218:05 amRNSRe-admission of Ordinary shares
22nd Oct 20213:02 pmRNSCompletion of Golden Eagle Acquisition
22nd Oct 20211:27 pmRNSHolding(s) in Company
20th Oct 20212:00 pmRNSPublication of Supplementary Prospectus
14th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20215:07 pmRNSPublication of Supplementary Prospectus
29th Sep 202110:29 amRNSHolding(s) in Company
2nd Sep 20217:00 amRNSHalf-year Results
20th Aug 20213:35 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSHolding(s) in Company
30th Jul 20213:22 pmRNSDirector/PDMR Shareholding
29th Jul 202110:18 amRNSHolding(s) in Company
26th Jul 20217:00 amRNSAdmission of New Shares
23rd Jul 202111:21 amRNSResults of Capital Raising and General Meeting
9th Jul 20211:00 pmRNSGeneral Meeting Notice Amendment
6th Jul 20217:00 amRNSBentley transaction completion
30th Jun 20215:12 pmRNSPublication of Combined Circular and Prospectus
30th Jun 20214:17 pmRNSCompletion of Firm Placing and Placing
30th Jun 20217:00 amRNSProposed Firm Placing and Placing and Open Offer
25th May 202110:00 amRNSPayments to governments
12th May 20214:26 pmRNSAGM Statement
12th May 20217:00 amRNSOperations update
5th May 20214:21 pmRNSDirector/PDMR Shareholding
26th Apr 20212:11 pmRNSDirector/PDMR Shareholding
26th Apr 20217:00 amRNSAgreement to acquire Bentley discovery
19th Apr 20213:34 pmRNSDirector/PDMR Shareholding
16th Apr 202110:00 amRNSHolding(s) in Company
15th Apr 20214:31 pmRNSHolding(s) in Company
15th Apr 20214:00 pmRNSAnnual Financial Report
30th Mar 20212:34 pmRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSResults for the year ended 31 December 2020
2nd Mar 20218:00 amRNSHolding(s) in Company
25th Feb 20219:00 amRNSHolding(s) in Company
25th Feb 20217:00 amRNSEagle discovery farm-down

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.